Since HOXC8 expression is up-regulated in NSCLC patients’ samples compared to normal lung tissues (Fig. 1), the expression of HOXC8 might contribute to poor response to chemotherapy in NSCLC patients. Here, HOXC8 is linked to non-small cell lung carcinoma.